Skip to main content

$0.330 0.010 (3.13%)

High

$0.34

Low

$0.31

Trades

12

Turnover

$48,258

Volume

147,149
30 June 2023 at 2:58pm
Register to track IMR and receive email alerts.
Subject
IMR Ann: Notification of cessation of securities - IMR

IMR Ann: Appendix 3Y - SW

IMR Ann: Notification regarding unquoted securities - IMR

IMR Ann: Release from Voluntary Escrow

IMR Ann: Appendix 3Y - PM

IMR Ann: Appendix 3Y - AM

IMR Ann: Appendix 3Y - MT

IMR Ann: Application for quotation of securities - IMR

IMR Ann: Results of Meeting

IMR Ann: Annual Stockholder Meeting Presentation Slides

IMR Ann: Annual Meeting Of Stockholders Chair's Address

IMR Ann: Imricor Q1 FY23 Quarterley Activities Report and Appendix 4C

IMR Ann: Imricor's Products to Operate with GE Healthcare MRI Systems

IMR Ann: Notification of cessation of securities - IMR

IMR Ann: Business Update - Correction

IMR Ann: Business Update

IMR Ann: Imricor Establishes First iCMR Site in Switzerland

IMR Ann: Letter to Shareholders and Online Meeting Guide

IMR Ann: Notice of Annual Stockholders Meeting and CDI Voting Form

IMR Ann: Appendix 4G and Corporate Governance Statement

IMR Ann: Annual Report to shareholders

IMR Ann: Notification regarding unquoted securities - IMR

IMR Ann: Cleansing Notice - Convertible Note Tranche 2

IMR Ann: Appendix 3B - Tranche 2 Convertible Note and Warrants

IMR Ann: Appendix 3Y - MT

IMR Ann: NWR Virtual Healthcare Conference

IMR Ann: Appendix3Y - MT

IMR Ann: Appendix 3Y - SW

IMR Ann: Results of Meeting

IMR Ann: FY22 Results Investor Presentation

IMR Ann: Imricor Releases FY22 Results

IMR Ann: Appendix 4E and FY22 Financial Accounts

IMR Ann: Online Meeting Guide

IMR Ann: Notice of Extraordinary General Meeting/Proxy Form

IMR Ann: Ceasing to be a substantial holder

IMR Ann: FY22 Results Webinar

IMR Ann: Change in substantial holding

IMR Ann: Change in substantial holding

IMR Ann: Imricor and GE HealthCare MOU for Collaboration

IMR Ann: Imricor Receives IDE Approval from US FDA

IMR Ann: Imricor Q4 FY22 Quarterley Activities Report and Appendix 4C

IMR Ann: Notification of cessation of securities - IMR

IMR Ann: Notification regarding unquoted securities - IMR

IMR Ann: Cleansing Notice - Convertible Note Tranche 1

IMR Ann: Appendix 3B - Tranche 1 Convertible Note and Warrants

IMR Ann: Imricor Recives North Dakota US$1.5m LIFT Loan Approval

IMR Ann: Notification of cessation of securities - IMR

IMR Ann: Imricor to Raise US$5 million via Convertible Note

IMR Ann: VISABL-VT Ethics Committee Approval and NorthStar-MR Update

IMR Ann: US$5 Million Convertible Note and Business Update

Register to track IMR and receive email alerts.